MaxCyte (MXCT) Earnings Date & Reports

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MXCT is expected to report earnings to fall 5.00% to -9 cents per share on August 06

Q2'25

Est.

$-0.09

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.03

The last earnings report on May 07 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 389.60K shares outstanding, the current market capitalization sits at 450.26M.

View a ticker or compare two or three

Compare

MXCT